CME Group has sued the U.S. Commodity Futures Trading Commission and its chairman, Michael Selig, arguing the agency illegally reclassified crypto perpetual contracts as futures rather than swaps — a move CME says sidesteps Congress and established rulemaking procedures.
What happened
- The lawsuit follows recent CFTC approvals that let U.S. platforms list regulated perpetual futures. Some of those products have already drawn heavy trading — early approvals reportedly cleared products that generated more than $1 billion in volume, and Kalshi later said its new perpetual business did over $5.5 billion in volume within weeks after launching Bitcoin, Ethereum, XRP and other contracts.
- Kalshi’s Bitcoin perpetual (BTCPERP) was approved on May 29. Coinbase also secured a regulated route to offer certain perpetuals in the U.S. via infrastructure tied to Deribit, the derivatives exchange it acquired.
CME’s case
- CME contends the CFTC misapplied the law by treating perpetuals as futures when, under the Dodd‑Frank framework, they should be categorized as swaps. According to the complaint, the agency abandoned prior practice (in which similar perpetual-style instruments were treated as swaps), effectively creating a new regulatory framework without formal rulemaking congressionally required for swaps.
- CME also raises commercial concerns: CEO Terrence Duffy told CNBC the exchange has exclusive agreements with certain benchmark providers and argues related products should be routed through CME regardless of contract form. The complaint cites intellectual property and licensing issues tied to that claim.
CFTC response and broader reactions
- A CFTC spokesperson framed the lawsuit as a choice to litigate rather than compete, describing the challenge as resistance from incumbents to a pro‑innovation regulatory stance by the Trump administration.
- Legal commentators note the dispute is legally complex. StarkWare General Counsel Katherine Kirkpatrick observed that recent court decisions reduce deference to agencies, which may help CME’s statutory arguments — but she also pointed out that the CFTC has previously treated certain perpetuals as swaps in enforcement actions (e.g., Binance), even if those positions are not binding precedent.
- Kirkpatrick added that federal law does not necessarily require the CFTC to wait 45 days or maintain a quorum before acting, which could support the chair’s authority to approve products. She also cautioned that CME will need to show actual competitive harm; offshore perpetual venues already compete with U.S. markets. Finally, she suggested perpetuals are a novel enough product that Congress may not have explicitly anticipated them when passing Dodd‑Frank, giving the CFTC some discretion in how to categorize them.
Why it matters
- The case could determine how perpetual contracts are regulated in the U.S., affecting who can list them, what rules apply, and whether market makers and exchanges must follow swap‑specific procedures.
- It also highlights the tension between legacy exchanges seeking to protect market share and new entrants using novel contract structures to attract traders away from offshore venues.
What’s next
- The lawsuit will proceed through federal court. Its outcome could reshape CFTC authority over novel derivatives, influence future product approvals, and set precedents for how the U.S. treats perpetual-style crypto products.
Sources: CME complaint (reported by Bloomberg), statements to CNBC, Kalshi and Coinbase disclosures, and commentary from Katherine Kirkpatrick on X.
Read more AI-generated news on: undefined/news
